Utah Medical Products, Inc. Stock
Equities
UTMD
US9174881089
Medical Equipment, Supplies & Distribution
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
67.76 USD | +0.39% | -3.03% | -19.86% |
Financials (USD)
Sales 2022 | 52.28M | Sales 2023 | 50.22M | Capitalization | 306M |
---|---|---|---|---|---|
Net income 2022 | 16M | Net income 2023 | 16M | EV / Sales 2022 | 5.55 x |
Net cash position 2022 | 74.66M | Net cash position 2023 | 92.53M | EV / Sales 2023 | 4.24 x |
P/E ratio 2022 |
22.2
x | P/E ratio 2023 |
18.4
x | Employees | 180 |
Yield 2022 |
1.16% | Yield 2023 |
1.41% | Free-Float | 93.37% |
1 day | +0.02% | ||
1 week | -3.03% | ||
Current month | -1.17% | ||
1 month | -1.82% | ||
3 months | -2.63% | ||
6 months | -16.17% | ||
Current year | -19.86% |
Managers | Title | Age | Since |
---|---|---|---|
Kevin Cornwell
CEO | Chief Executive Officer | 77 | 92-11-30 |
Brian Koopman
DFI | Director of Finance/CFO | 54 | 05-12-31 |
Paul Richins
BRD | Director/Board Member | 63 | 89-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kevin Cornwell
CEO | Chief Executive Officer | 77 | 92-11-30 |
Ernst Hoyer
BRD | Director/Board Member | 86 | 95-12-31 |
Paul Richins
BRD | Director/Board Member | 63 | 89-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.27% | 26 M€ | -4.54% | - | |
0.00% | 9 M€ | +9.79% | - | |
0.00% | 18 M€ | +3.94% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-10 | 67.49 | +0.15% | 10 993 |
24-06-07 | 67.39 | +0.10% | 18,098 |
24-06-06 | 67.32 | -0.01% | 5,289 |
24-06-05 | 67.33 | -1.59% | 9,107 |
24-06-04 | 68.42 | -1.70% | 11,771 |
Delayed Quote Nasdaq, June 10, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-19.86% | 238M | |
-2.99% | 187B | |
+0.40% | 109B | |
-2.35% | 69.22B | |
-6.16% | 46.36B | |
+13.45% | 46.19B | |
+8.48% | 42.44B | |
+18.06% | 30.84B | |
+19.69% | 25.73B | |
-9.53% | 23.3B |
- Stock Market
- Equities
- UTMD Stock